Alembic Pharma receives USFDA nod for Bimatoprost Ophthalmic Solution Farhat Nasim15 April 2019 4:35 AM GMTBimatoprost Ophthalmic Solution, 0.03% is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular...
Sun Pharma and SPARC's XELPROS gets USFDA approval Medical Dialogues Bureau15 Sep 2018 11:02 AM GMTUS Food and Drug Administration (USFDA) has approved the SPARC new drug application of XELPROS, used to reduce glaucoma open-angle glaucoma or ocular...